Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway

Diabetic nephropathy (DN) is the leading cause of end-stage failure of the kidney, but the efficacy of current strategies available for the prevention of DN remains unsatisfactory. The purpose of this study was to assess whether sitagliptin (SIT) has therapeutic potential for prevention of DN and to...

全面介紹

Na minha lista:
書目詳細資料
發表在:Int J Mol Med
Main Authors: Wang, Dongdong, Zhang, Guanying, Chen, Xiao, Wei, Tong, Liu, Chenxu, Chen, Chun, Gong, Yinhan, Wei, Qunli
格式: Artigo
語言:Inglês
出版: D.A. Spandidos 2018
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846674/
https://ncbi.nlm.nih.gov/pubmed/29484381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3504
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍